Sanofi has now received approval for the use of Dengvaxia, a new vaccine against Dengue fever, in Brazil, Mexico and the Philippines. The vaccine has been tested in patients within the age range of 9-45 years, in whom three vaccination rounds resulted in the prevention of the 4 forms of Dengue fever in 65% of…Continue reading A vaccine for Dengue fever?